Log In
Print
BCIQ
Print
Print this Print this
 

Truvada, emtricitabine/tenofovir

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionFixed-dose combination of the nucleoside analog reverse transcriptase inhibitors (NRTI) emtricitabine and tenofovir
Molecular Target HIV reverse transcriptase
Mechanism of ActionHIV reverse transcriptase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsPre-exposure prophylaxis (PrEP) to reduce risk of HIV-1 infection in uninfected adults; Pre-exposure prophylaxis (PrEP) to reduce risk of HIV-1 infection in uninfected adults in combination with safer sex practices; Prevent HIV infection; Prevent HIV infection in women; Treat HIV infection; Treat HIV infection/AIDS in antiretroviral-naïve patients
Regulatory Designation

Partner

Bristol-Myers Squibb Co.; Mylan Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today